Список литературы

    1. Аветисов С.Э., Киселева Т.Н., Воробьева М.В., Будзинская М.В. и др. Значение метода аутофлюоресценции в диагностике патологии глазного дна // Вестник офтальмологии. – 2011. - № 5. – С. 49-53.

    2. Балашевич Л.И., Гацу М.В., Искендерова Н.Г. Эффективность диодной субпороговой микроимпульсной лазеркоагуляции при лечении различных форм центральной серозной ретинопатии//Тез. докл. IV Всерос. семинара - «Круглый стол» — «Макула». - Ростов-на-Дону, 2010. – С.416-418.

    3. Березин Ю.Д. Экспериментальное обоснование предельно допустимых уровней прямого импульсного лазерного излучения для органа зрения. – Ленинград, 1988. – 45 с.

    4. Большунов А.В., Федорук Н.А., Федоров А.А. Субпороговые технологии лазерного лечения макулярной патологии (транспупиллярная термотерапия, субпороговая микроимпульсная лазеркоагуляция)/В кн.: Вопросы лазерной офтальмологии. – Москва, 2013. – С. 230-248.

    5. Гацу М.В., Искендерова Н.Г. Ятрогенные осложнения надпороговой лазеркоагуляции при лечении центральной серозной хориретинопатии// Тез. докл. III Всерос. семинара - «Круглый стол» — «Макула». – Ростов-на-Дону, 2008. – С. 92-95.

    6. Желтов Г.И. Биофизика деструктивного действия надпорогового лазерного излучения на ткани глазного дна//Тез. докл. II Всерос. семинара - «Круглый стол» — «Макула». – Ростов-на-Дону, 2006. – С. 71-85.

    7. Желтов Г.И. Воздействие интенсивного оптического света на ткани глаз: исследования и приложения: Автореф. дис. д-ра физ.-мат. наук. – Минск, 1996. – 92 с.

    8. Желтов Г.И., Иванишко Ю.А., Большунов А.В. Нетермальная (механическая) фрагментация интраокулярных структур короткими импульсами лазерного излучения//Тез. докл. III Всерос. семинара - «Круглый стол» — «Макула». – Ростов-на-Дону, 2008. – С. 50-56.

    9. Желтов Г.И., Романов Г.С., Романов О.Г., Иванова Е.В. Селективное действие лазерных импульсов на ретинальный пигментный эпителий. Физические основы//Новое в офтальмологии. – 2012. - №3. – С. 37-43.

    10. Журавлева Е.С. Инфракрасное микроимпульсное диодное лазерное излучение при лечении макулярной патологии (экспериментально-клиническое исследование): Дис. к-та мед. наук.- Москва, 2011. – 154 с.

    11. Злобина А.Н., Малышев В.В., Юрьева Т.Н., Щуко А.Г. Показания и эффективность различных методов лечения хронической центральной серозной хориоретинопатии//Практическая медицина. - 2012. - № 4. - С. 105-107.

    12. Иванова Е.В. Влияние лазерного лечения на структурно-функциональные нарушения центральной зоны сетчатки, выявленные после микроинвазивной эндовитреальной хирургии отслойки сетчатки: Автореф. дис. к-та мед. наук. – Москва, 2010. – 27 с.

    13. Коскас Г., Коскас Ф., Зурдан А. Центральная серозная хориоретинопатия/В кн.: Комплексная диагностика патологии глазного дна. Цветной атлас. Под ред. В.В. Нероева, М.В. Рябиной: Пер. с франц. – М.:«Практическая медицина», 2007. - С. 259-292.

    14. Коэн С.-И., Квинтель Г. Флюоресцентная ангиография в диагностике патологии глазного дна. Под ред. Нероева В.В., Рябиной М.В: Пер. с франц. – М.: Рейтар, 2005. – 311 с.

    15. Мирзабекова К.А., Федорук Н.А. Лазеры в лечении центральной серозной хориоретинопатии/В кн.: Вопросы лазерной офтальмологии. – Москва, 2013. – С. 249-255.

    16. Мутиков И.В., Мазунин И.Ю., Павлова А.Ю. Отдаленные результаты лечения центральной серозной хориоретинопатии (ЦСХРП) с юкста-субфовеолярной локализацией точки фильтрации с помощью субпорогового микроимпульсного инфракрасного лазерного воздействия (СМИЛВ)//Практическая медицина. - 2012. - № 4. - С. 123-127.

    17. Педанова Е.К. Микропериметрия в оценке функционального состояния и комплексном прогнозировании результатов хирургического лечения пациентов с идиопатическим макулярным разрывом: дис. к-та мед. наук. – Москва, 2009. – 136 с.

    18. Чиковани К.Р. Диагностические критерии и дифференцированный подход к лечению различных форм центральной серозной хориоретинопатии: Автореф. дис. к-та мед. наук. – Москва, 2011. – 26 с.

    19. Щеголева И.В., Будзинская М.В. Этиология и патогенез центральной серозной хориоретинопатии // Вестник офтальмологии. – 2010. - №3. – С. 55-58.

    20. Ahlers C., Geitzenauer W., Stock G., et al. Alterations of intraretinal layers in acute central serous chorioretinopathy // Acta Ophthalmol. – 2009. – Vol.87. – P. 511–516.

    21. Arndt C., Sari A., Ferre M., et al. Electrophysiological effects of corticosteroids on the retinal pigment epithelium // Invest. Ophthalmol. Vis. Sci. – 2001. –Vol.42. – P. 472-475.

    22. Ayata A., Tatlipinar S., Kar T., et al. Near infrared and short-wavelength autofluorescence imaging in central serous chorioretinopathy // Br. J. Ophthalmol. – 2009. – Vol.93. – P. 79–82.

    23. Bouzas E.A., Scott M.H., Mastorakos G., et al. Central serous chorioretinopathy in endogenous hypercortisolism // Arch. Ophthalmol. - 1993. - Vol.111. - P. 1229-1233.

    24. Bujarborua D. Long-term follow-up of idiopathic central serous chorioretinopathy without laser // Acta Ophthalmol. Scand. – 2001. – Vol.79. – P. 417-421.

    25. Caccavale A., Romanazzi F., Imparato M., et al. Central serous chorioretinopathy: a pathogenetic model // Clin. Ophthalmol. – 2011. – Vol.5. – P. 239-243.

    26. Caccavale A., Romanazzi F., Imparato M., et al. Low-dose aspirin as treatment for central serous chorioretinopathy // Clin. Ophthalmol. – 2010. - Vol.4. – P. 899-903.

    27. Cardillo J.A. Micropulse Laser for Treatment of DME and CSC // Retina Today. - 2012. - P. 52-55.

    28. Carvalho-Recchia C.A., Yannuzzi L.A., Negrao S., et al. Corticosteroids and central serous chorioretinopathy // Ophthalmol. – 2002. – Vol.109. – P. 1834-1837.

    29. Cassel G.H., Brown G.C., Annesley W.H. Central serous chorioretinopathy: a seasonal variation? // Br. J. Ophthalmol. – 1984. – Vol.68. – P. 724-726.

    30. Chan W.M., Lam D.S., Lai T.Y., et al. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level // Br. J. Ophthalmol. – 2003. – Vol.87. – P. 1453-1458.

    31. Chappelow A.V., Marmor M.F. Multifocal electroretinogram abnormalities persist following resolution of central serous chorioretinopathy // Arch. Ophthalmol. – 2000. – Vol.118. – P. 1211-1215.

    32. Chen S.J., Lee A.F., Lee F.L., Liu J.H. Indocyanine green angiography of central serous chorioretinopathy // Zhonghua. Yi. Xue. Za. Zhi. (Taipei). – 1999. – Vol.62, № 9. – P. 605-613.

    33. Chrapek O., Spackova K., Rehak J. Treatment of central serous chorioretinopathy with beta blockers // Cesk. Slov. Oftalmol. – 2002. –Vol.58. – P. 382-386.

    34. Chumbley L.C., Frank R.N. Central serous retinopathy and pregnancy // Am. J. Ophthalmol. - 1974. - Vol.77. - P. 158-160.

    35. Cotticelli L., Borrelli M., D’Alessio A.C., et al. Central serous chorioretinopathy and Helicobacter pylori // Eur. J. Ophthalmol. – 2006. – Vol.16. – P. 274-278.

    36. Cox S.N., Hay E., Bird A.C. Treatment of chronic macular edema with acetazolamide // Arch. Ophthalmol. - 1988. - Vol.106. - P. 1190-1195.

    37. Dang Y., Sun X., Xu Y., et al. Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathy // Ther. Clin. Risk. Manag. – 2014. – Vol.9, № 10. – P. 37-43.

    38. Desai U.R., Alhalel A.A., Campen T.J., et al. Central serous chorioretinopathy in African Americans // J. Natl. Med. Assoc. – 2003. – Vol.95. – P. 553-559.

    39. Desmettre T.J., Mordon S.R., Buzawa D.M., Mainster M.A. Micropulse and continuous wave diode retinal photocoagulation: visible and subvisible lesion parameters // Br. J. Ophthalmol. – 2006. – Vol.90, № 6. – P. 709-712.

    40. Dorey C.K., Torres X., Swart T. Evidence of melanogenesis in porcine retinal pigment epithelial cells in vitro // Exp. Eye. Res. – 1990. – Vol.50. – P. 1-10.

    41. Dorin G. Evolution of retinal laser therapy: minimum intensity photocoagulation (MIP). Can the laser heal the retina without harming it? // Semin. Ophthalmol. – 2004. – Vol.19, № 1-2. – P. 62-68.

    42. Dorin G. Subthreshold and micropulse diode laser photocoagulation // Semin. Ophthalmol. – 2003. – Vol.18, № 3. – P. 147-153.

    43. Fawzi A.A., Holland G.N., Kreiger A.E., et al. Central serous chorioretinopathy after solid organ transplantation // Ophthalmol. – 2006. – Vol.113. – P. 813-815.

    44. Ficker L., Vafidis G., While A., Leaver P. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy // Br. J. Ophthalmol. – 1988. – Vol.72. – P. 829-834.

    45. Flaxel C., Bradle J., Acott T., et al. Retinal pigment epithelium produces matrix metalloproteinases after laser treatment // Retina. – 2007. – Vol.27. – P. 629-634.

    46. Forooghian F., Meleth A.D., Cukras C., et al. Finasteride for chronic central serous chorioretinopathy // Retina. – 2011. – Vol.31. – P. 766-771.

    47. Framme C., Alt C., Schnell S., et al. Selective targeting of the retinal pigment epithelium in rabbit eyes with a scanning laser beam // Invest. Ophthalmol. Vis. Sci. – 2007. - Vol.48, №4. – P. 1782-1792.

    48. Framme C., Brinkmann R., Birngruber R., Roider J. Autofluorescence imaging after selective RPE laser treatment in macular diseases and clinical outcome: a pilot study // Br. J. Ophthalmol. – 2002. – Vol.86, № 10. - P. 1099-1106.

    49. Framme C., Schuele G., Kobuch K., et al. Investigation of selective retina treatment (SRT) by means of 8 ns laser pulses in a rabbit model // Lasers. Surg. Med. – 2008. – Vol.40, №1. - P. 20-27.

    50. Framme C., Walter A., Gabler B., et al. Fundus autofluorescence in acute and chronic recurrent central serous chorioretinopathy // Acta Ophthalmol. Scand. – 2005. - Vol.83, № 2. – P. 161-167.

    51. Fujita K., Shinoda K., Imamura Y., et al. Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy // Am. J. Ophthalmol. – 2012. – Vol.154, № 3. – P. 579-585.

    52. Gass J.D.M. Pathogenesis of disciform detachment of the neuroepithelium-I: general concepts and classification // Am. J. Ophthalmol. – 1967. - Vol.63, № 3. – P. 573-585.

    53. Gass J.D.M. Photocoagulation treatment of idiopathic central serous chorioretinopathy // Trans. Am. Acad. Ophthalmol. Otolaryngol. – 1977. – Vol.83. – P.456–467.

    54. Gass J.D.M., Little H.L. Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy // Ophthalmol. – 1995. – Vol.102. – P.737-747.

    55. Gemenetzi M., Salvo G.D., Lotery A.J. Central serous chorioretinopathy: an update on pathogenesis and treatment // Eye. – 2010. – Vol.24. – P. 1743-1756.

    56. Golshahi A., Klingmuller D., Holz F.G., et al. Ketoconazole in the treatment of central serous chorioretinopathy: a pilot study // Acta Ophthalmol. – 2010. – Vol.88, № 5. – P. 576-581.

    57. Gomolin J.E. Choroidal neovascularization and central serous chorioretinopathy // Can. J. Ophthalmol. – 1989. – Vol.24. – P. 20–23.

    58. Gupta G., Elagouz M., McHugh D., et al. Micropulse diode laser photocoagulation for central serous chorio-retinopathy // Clin. Exp. Ophthalmol. - 2009. – Vol.37. – P. 801-805.

    59. Gupta V., Gupta P., Dogra M.R., Gupta A. Spontaneous closure of retinal pigment epithelium microrip in the natural course of central serous chorioretinopathy // Eye. – 2010. – Vol.24. – P. 595-599.

    60. Guyer D.R., Yannuzzi L.A., Slakter J.S. et al. Digital indocyanine green videoangiography of central serous chorioretinopathy // Arch Ophthalmol. - 1994. - Vol.112. - P. 1057-1062.

    61. Gackle H.C., Lang G.E., Freissler K.A., Lang G.K. Clinical, fluorescein angiographic and demographic aspects in central serous chorioretinopathy // Ophthalmol. – 1998. – Vol.95. – P. 529-533.

    62. Haimovichi R., Gragoudas E.S., Duker J.S. et al. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids // Ophthalmol. - 1997. - Vol.104. - P. 1653-1960.

    63. Haimovichi R., Koh S., Gagnon D. et al. Risk factors for central serous chorioretinopathy. A case control study. // Ophthalmol. - 2004. - Vol.111. - P. 244-249.

    64. Hattenbach L.O., Beck K.F., Pfeilschifter J., et al. Pigment-epithelium-derived factor is upregulated in photocoagulated human retinal pigment epithelial cells // Ophthalmic Res. – 2005. – Vol.37, № 6. – P. 341-346.

    65. Heinrich M.R. Central serous retinopathy and alphablockaders // Bull. Soc. Ophtalmol. Fr. – 1974. – Vol.74. P. 681-683.

    66. Hirami Y., Tsujikawa A., Sasahara M. et al. Alterations of retinal pigment epithelium in central serous chorioretinopathy // Clin. Experiment. Ophthalmol. – 2007. - Vol.35, № 3. – P. 225-230.

    67. Horniker E. Su di una forma retinite centrale di origin vasoneurotica (retinite central capillo-spastica) // Ann. Ottal. - 1927. - Vol.55. - P. 578-600.

    68. Hu D.N., Simon J.D., Sarna T. Role of ocular melanin in ophthalmic physiology and pathology // Photochem. Photobiol. – 2008. – Vol.84. – P. 639-644.

    69. Hussain N., Khanna R., Hussain A., Das T. Transpupillary thermotherapy for chronic central serous chorioretinopathy // Graefes. Arch. Clin. Exp. Ophthalmol. – 2006. – Vol.244. – P. 1045-1051.

    70. Iida T., Spaide R.F., Haas A., et al. Leopard spot pattern of yellowish subretinal deposits in central serous chorioretinopathy // Arch. Ophthalmol. – 2002. – Vol.120. - P. 37-42.

    71. Iida T., Spaide R.F., Negrao S.G. et al. Central serous chorioretinopathy after epidural corticosteroid injection // Am. J. Ophthalmol. - 2001. - Vol.132. - P. 423-425.

    72. Imamura Y., Fujiwara T., Margolis R., et al. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy // Retina. – 2009/ - Vol.29. – P. 1469-1473.

    73. Imamura Y., Fujiwara T., Spaide R.F. Fundus autofluorescence and visual acuity in central serous chorioretinopathy // Ophthalmol. – 2011. – Vol.118. – P. 700-705.

    74. Jain A., Blumenkranz M.S., Paulus Y., et al. Effect of pulse duration on size and character of the lesion in retinal photocoagulation // Arch. Ophthalmol. – 2008. – Vol.126, № 1. – P. 78-85.

    75. Jain I.S., Singh K. Maculopathy a corticosteroid side-effect // J. All. India. Ophthalmol. Soc. – 1966. – Vol.14. – P. 250-252.

    76. Jampol L.M., Weinreb R., Yannuzzi L. Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies // Ophthalmol. - 2002. - Vol.109. - P. 1765-1766.

    77. Kanagawa M., Matsubara M. Xenon light-exposure as a treatment of central serous retinopathy // Nippon. Ganka. Kiyo. – 1970. – Vol.6. – P. 451-453.

    78. Karadimas P., Kapetanios A., Bouzas E. Central serous chorioretinopathy after local application of glucocorticoids for skin disorders // Arch. Ophthalmol. - 2004. - Vol.122. - P. 784-786.

    79. Keilhauer C.N., Delori F.C. Near-infrared autofluorescence imaging of the fundus: visualization of ocular melanin // Invest. Ophthalmol. Vis. Sci. – 2006. - Vol.47, № 8. – P. 3556-3564.

    80. Kim S.R., Nakanishi K., Itagaki Y., et al. Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin // Exp. Eye Res. – 2006. – Vol.82. – P. 828-839.

    81. Kim S.W., Oh J., Kwon S.S., Yoo J., et al. Comparison of choroidal thickness among patients with healthy eyes, early age related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy // Retina. – 2011. – Vol.31. – P. 1904-1911.

    82. Kim S.W., Oh J., Oh I.K., et al. Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy // Ophthalmic. Surg. Lasers Imaging. – 2009. – Vol.40. – P. 300-303.

    83. King G.L., Suzuma K. Pigment-epithelium-derived factor--a key coordinator of retinal neuronal and vascular functions // N. Engl. J. Med. – 2000. – Vol.342, № 5. – P. 349-351.

    84. Kitaya N., Nagaoka T., Hikichi T. Features of abnormal choroidal circulation in central serous chorioretinopathy // Br. J. Ophthalmol. – 2003. – Vol.87. – P. 709-712.

    85. Klatt C., Saeger M., Oppermann T., et al. Selective retina therapy for acute central serous chorioretinopathy // Br. J. Ophthalmol. – 2011. – Vol.95, - № 1. –P. 83-88.

    86. Koskela P., Laatikainen L., von Dickhoff K. Contrast sensitivity after resolution of central serous retinopathy // Graefes. Arch. Clin. Exp. Ophthalmol. -1994. – Vol.232. – P. 473-476.

    87. Koss M. Treating Chronic Central Serous Chorioretinopathy // Retina Today. – 2013. – P. 68-70.

    88. Koss M.J., Beger I., Koch F.H. Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy // Eye. – 2012. – Vol.26, № 2. – P. 307-314.

    89. Lai T.Y., Lai R.Y., Ngai J.W., et al. First- and second-order kernel multifocal electroretinography abnormalities in acute central serous chorioretinopathy // Doc. Ophthalmol. – 2008. – Vol.116. – P. 29-40.

    90. Lanzetta P., Dorin G., Pirracchio A., Bandello F. Theoretical bases of non-ophthalmoscopically visible endpoint photocoagulation // Semin. Ophthalmol. - 2001. – Vol.16, № 1. – P. 8-11.

    91. Lanzetta P., Furlan F., Morgante L., et al. Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study // Eur. J. Ophthalmol. – 2008. – Vol.18, № 6. – P. 934-940.

    92. Lavinsky D., Sramek C., Wang J., et al. Subvisible retinal laser therapy: titration algorithm and tissue response // Retina. – 2014. – Vol.34, № 1. – P. 87-97.

    93. Leaver P., Williams C. Argon laser photocoagulation in the treatment of central serous retinopathy // Br. J. Ophthalmol. – 1979. – Vol.63. – P. 674-677.

    94. Levine R., Brucker A. J., Robinson F. Long-term follow-up of idiopathic central serous choriorethinopathy by fluorescein angiography // Ophthalmol. – 1989. - Vol.96. – P. 854-859.

    95. Lim J.W., Kim M.U. The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy // Graefes. Arch. Clin. Exp. Ophthalmol. - 2011. – Vol.249. – P. 969-974.

    96. Lim J.W., Kim M.U., Shin M.C. Aqueous humor and plasma levels of vascular endothelial growth factor and interleukin-8 in patients with central serous chorioretinopathy // Retina. – 2010. – Vol.30. – P. 1465-1471.

    97. Lim J.W., Ryu S.J., Shin M.C. The effect of intravitreal bevacizumab in patients with acute central serous chorioretinopathy // Korean J. Ophthalmol. – 2010. –Vol.24. – P.155-158.

    98. Lin E., Arrigg P.G., Kim R.Y. Familial central serous choroidopathy // Graefes. Arch. Clin. Exp. Ophthalmol. – 2000. – Vol.238. – P. 930-931.

    99. Luttrull J.K., Dorin G. Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review // Curr. Diabetes Rev. – 2012. – Vol.8, № 4. – P. 274-284.

    100. Maia A. Micropulse Treatment for Central Serous Retinopathy // Retina Today. -2010. – P. 7-8.

    101. Mainster M.A. Continuous-wave and Micropulse 577 nm Yellow Laser Photocoagulation: A Laser for All Reasons // Retina Today. – 2010. – P. 1-3.

    102. Mainster M.A. Decreasing retinal photocoagulation damage: principes and techniques // Semin. Ophthalmol. – 1999. – Vol.14, № 4. – P. 200-209.

    103. Mainster M.A.Wavelength selection in macular photocoagulation.Tissue optics, thermal effects, and laser systems // Ophthalmol. – 1986. – Vol.93. – P. 952-958.

    104. Maruko I., Iida T., Ojima A., et al. Subretinal dot-like precipitates and yellow material in central serous chorioretinopathy // Retina. – 2011. – Vol.31. – P. 759-765.

    105. Maruko I., Iida T., Sugano Y., et al. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy // Retina. - 2011. – Vol.31, № 8. – P. 1603-1608.

    106. Matsumoto H., Kishi S., Otani T., Sato T. Elongation of photoreceptor outer segment in central serous chorioretinopathy // Am. J. Ophthalmol. – 2008. –Vol.145. – P. 162-168.

    107. Matsumoto H., Kishi S., Sato T., Mukai R. Fundus autofluorescence of elongated photoreceptor outer segments in central serous chorioretinopathy // Am. J. Ophthalmol. – 2011. – Vol.151. – P. 617-623.

    108. Maumenee A.E. Symposium: macular diseases, clinical manifestations // Trans. Am. Acad. Ophthalmol. Otolaryngol. – 1965. – Vol.69. – P. 605-613.

    109. Meyerle C.B., Freund K.B., Bhatnagar P., et al. Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy // Retina. – 2007. –Vol.27. – P. 943-946.

    110. Michael J.C., Pak J., Pulido J., de Venecia G. Central serous chorioretinopathy associated with administration of sympathomimetic agents // Am. J. Ophthalmol. – 2003. – Vol.136. – P. 182-185.

    111. Miki T., Sunada I., Higaki T. Studies of chorioretinitis induced in stress (repeated injection of epinephrine) // Acta Soc. Ophthalmol. Jpn. - 1972. - Vol.75. - P. 1037-1045.

    112. Mondal L.K., Sarkar K., Datta H., Chatterjee P.R. Acute bilateral central serous chorioretinopathy following intra-articular injection of corticosteroid // Indian J. Ophthalmol. – 2005. – Vol.53. – P. 132-134.

    113. Murphy R.P. True Yellow 577 for the Treatment of Retinal Disorders: Searching for the Holy Grail // Retina Today. – 2010. - P. 5-7.

    114. Nair U., Ganekal S., Soman M., Nair K. Correlation of spectral domain optical coherence tomography findings in acute central serous chorioretinopathy with visual acuity // Clin. Ophthalmol. – 2012. – Vol.6. – P. 1949-1954.

    115. Nicholson B., Noble J., Forooghian F., Meyerle C. Central Serous Chorioretinopathy: Update on Pathophysiology and Treatment // Surv. Ophthalmol. – Vol.58, № 2. - 2013. - P. 103-119.

    116. Niegel M.F., Schrage N.F., Christmann S., Degenring R.F. Intravitreal bevacizumab for chronic central serous chorioretinopathy // Ophthalmol. – 2008. – Vol.105. – P. 943-945.

    117. Nielsen J.S., Jampol L.M. Oral mifepristone for chronic central serous chorioretinopathy // Retina. – 2011. – Vol.31. – P. 1928-1936.

    118. Noma H., Funatsu H., Mimura T. Pigment epithelium-derived factor is related to macular microcirculation in patients with macular edema and branch retinal vein occlusion // Int. Ophthalmol. – 2012. - Vol.32, № 5. – P. 485-489.

    119. Odrobina D., Laudanska-Olszewska I., Gozdek P., et al. Morphologic Changes in the Foveal Photoreceptor Layer before and after Laser Treatment in Acute and Chronic Central Serous Chorioretinopathy Documented in Spectral-Domain Optical Coherence Tomography. J. Ophthalmol. – 2013. – P. 1-6.

    120. Ogata N., Ando A., Uyama M., Matsumura M. Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells // Graefes. Arch. Clin. Exp. Ophthalmol. – 2001. – Vol.239, № 2. – P.87-95.

    121. Ogata N., Tombran-Tink J., Jo N., et al. Upregulation of pigment epithelium-derived factor after laser photocoagulation // Am. J. Ophthalmol. – 2001. – Vol.132, № 3. – P. 427-429.

    122. Ojima Y., Tsujikawa A., Hangai M., et al. Retinal sensitivity measured with the micro perimeter 1 year after resolution of central serous chorioretinopathy // Am. J. Ophthalmol. – 2008. – Vol.146. – P. 77-84.

    123. Ozdemir O., Erol M.K. Morphologic changes and visual outcomes in resolved central serous chorioretinopathy treated with ranibizumab // Cutan. Ocul. Toxicol. – 2014. – Vol. 33, № 2. – P. 122-126.

    124. Pankratov M. Pulsed delivery of laser energy in experimental thermal retinal photocoagulation // Proc. Soc. Photo-Optical Instrum. Eng. – 1990. – Vol.1202. – P. 205-213.

    125. Perkins S.L., Kim J.E., Pollack J.S., Merrill P.T. Clinical characteristics of central serous chorioretinopathy in women // Ophthalmol. – 2002. – Vol.109. – P. 262-266.

    126. Piccolino F.C., De La Longrais R.R., Manea M., Cicinelli S. Posterior cystoid retinal degeneration in central serous chorioretinopathy // Retina. – 2008. –Vol.28, № 7. – P. 1008-1012.

    127. Prunte C., Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy // Am. J. Ophthalmol. – 1996. – Vol.121. – P. 26-34.

    128. Ratanasukon M., Thongthong K., Bhurayanontachai P., Jirarattanasopa P. Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy // Clin. Ophthalmol. – 2013. – Vol.7. – P. 87-92.

    129. Ricci F., Missiroli F., Cerulli L. Indocyanine green dye-enhanced micropulsed diode laser: a novel approach to subthreshold RPE treatment in a case of central serous chorioretinopathy // Eur. J. Ophthalmol. – 2004. – Vol.14, № 1. – P. 74-82.

    130. Robertson D.M. Argon laser photocoagulation treatment in central serous chorioretinopathy // Ophthalmol. – 1986. – Vol.93. – P. 972-974.

    131. Robertson D.M., Ilstrup D. Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy // Am. J. Ophthalmol. - 1983. – Vol.95. – P. 457-466.

    132. Roider J., Brinkmann R., Wirbelauer C. Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study // Br. J. Ophthalmol. – 2000. – Vol.84, № 1. –P. 40-47.

    133. Roider J., Hillenkamp F., Flotte T., Birngruber R. Microphotocoagulation: selective effects of repetitive short laser pulses // Proc. Natl. Acad. Sci. U S A. – 1993. – Vol.90, №18. – P. 8643-8647.

    134. Roider J., Michaud N., Flotte T., Birngruber R. Histology of retinal lesions after continuous irradiation and selective micro-coagulation of the retinal pigment epithelium // Ophthalmol. – 1993. – Vol.90, № 3. – P. 274-278.

    135. Roisman L., Lavinsky D., Magalhaes F., et al. Fundus Autofluorescence and Spectral Domain OCT in Central Serous Chorioretinopathy // J. Ophthalmol. - 2011. – P. 1-4.

    136. Roisman L., Magalhaes F.P., Lavinsky D., et al. Micropulse diode laser treatment for chronic central serous chorioretinopathy: a randomized pilot trial // Ophthalmic. Surg. Lasers Imaging Retina. – 2013. – Vol.44, № 5. – P. 465-470.

    137. Roisman L., Ribeiro J.C., Fechine F.V., et al. Does microperimetry have a prognostic value in central serous chorioretinopathy? // Retina. – 2014. – Vol.34, № 4. – P. 713-718.

    138. Ruiz-Moreno J.M., Lugo F.L., Armada F., et al. Photodynamic therapy for chronic central serous chorioretinopathy // Acta Ophthalmol. – 2009. – Vol.88. – P. 371-376.

    139. Saxena S., Jain A. Alterations in “in vivo” histology of retina in bilateral chronic central serous chorioretinopathy after intravitreal bevacizumab // J. Ocul. Biol. Dis. Infor. – 2011. – Vol.4. – P. 137-140.

    140. Sekiryu T., Iida T., Maruko I., et al. Infrared Fundus Autofluorescence and Central Serous Chorioretinopathy // Invest. Ophthalmol. Vis. Sci. – 2010. - Vol.51, № 10. – P. 4956-4961.

    141. Sharma O., Rao N., Roy M. Sarcoidosis and central serous retinopathy: a dangerous combination // Sarcoidosis Vasc. Diffuse Lung. Dis. - 1998. - Vol.15. - P. 189-191.

    142. Sharma T., Parikh S.D. Transpupillary thermotherapy for juxtafoveal leak in central serous chorioretinopathy // Ophthalmic Surg. Lasers Imaging. – 2010. – P. 1-3.

    143. Shin M.C., Lim J.W. Concentration of cytokines in the aqueous humor of patients with central serous chorioretinopathy // Retina. – 2011. – Vol.31. – P. 1937-1943.

    144. Sibayan S.A., Kobuch K., Spiegel D. et al. Epinephrine, but not dexamethasone, induces apoptosis in retinal pigment epithelium cells in vitro: possible implications on the pathogenesis of central serous chorioretinopathy // Graefes. Arch. Clin. Exp. Ophthalmol. - 2000. - Vol.238. - P. 515-519.

    145. Spahn C., Wiek J., Burger T., Hansen L. Psychosomatic aspects in patients with central serous chorioretinopathy // Br. J. Ophthalmol. 2003. – Vol.87. – P. 704-708.

    146. Spaide R.F., Campeas L., Haas A. et al. Central serous chorioretinopathy in younger and older adults // Ophthalmol. - 1996. – Vol.103. – P. 2070-2079.

    147. Spaide R.F., Klancnik J.M. Fundus autofluorescence and central serous chorioretinopathy // Ophthalmol. – 2005. – Vol.112. – P. 825-833.

    148. Steinle N.C., Gupta N., Yuan A., Singh R.P. Oral rifampin utilisation for the treatment of chronic multifocal central serous retinopathy // Br. J. Ophthalmol. - 2012. – Vol.96, № 1. – P. 10-13.

    149. Sun J., Tan J., Wang Z., et al. Effect of catecholamine on central serous chorioretinopathy // J. Huazhong. Univ. Sci. Technolog. Med. Sci. - 2003. – Vol.23. – P. 313-316.

    150. Tewari H.K., Gadia R., Kumar D., et al. Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study // Invest. Ophthalmol. Vis. Sci. – 2006. – Vol.47. – P. 3474-3478.

    151. Tittl M., Polska E., Kircher K. et al. Topical fundus pulsation measurement in patients with active central serous chorioretinopathy // Arch. Ophthalmol. - 2003. - Vol.121. - P. 975-978.

    152. Ueda S., Yamagishi S.I., Okuda S. Anti-vasopermeability effects of PEDF in retinal-renal disorders // Curr. Mol. Med. – 2010. – Vol.10, № 3. – P. 279-283.

    153. Vajaranant T.S., Szlyk J.P., Fishman G.A., et al. Localized retinal dysfunction in central serous chorioretinopathy as measured using the multifocal electroretinogram // Ophthalmol. – 2002. – Vol.109. – P. 1243-1250.

    154. von Graefe A. Ueber centrale recidivierende retinitis // Graefes. Arch. Clin. Exp. Ophthalmol. – 1866. – Vol.12. – P. 211-215.

    155. von Winning C.H., Oosterhuis J.A., Renger-van Dijk A.H., et al. Diffuse retinal pigment epitheliopathy // Ophthalmologica. – 1982. – Vol.185. – P. 7-14.

    156. Wang M., Munch I.C., Hasler P.W., et al. Central serous chorioretinopathy // Acta Ophthalmol. – 2008. – Vol.86. – P. 126-145.

    157. Wang M., Sander B., la Cour M., Larsen M. Clinical characteristics of subretinal deposits in central serous chorioretinopathy // Acta Ophthalmol. Scand. – 2005. – Vol.83. – P. 691-696.

    158. Wang M.S., Sander B., Larsen M. Retinal atrophy in idiopathic central serous chorioretinopathy // Am. J. Ophthalmol. – 2002. - Vol.133, № 6. – P. 787-793.

    159. Wei S.Y., Yang C.M. Transpupillary thermotherapy in the treatment of central serous chorioretinopathy // Ophthalmic Surg. Lasers Imaging. – 2005. – Vol.36. – P. 412-415.

    160. Williamson T.H., Harris A. Ocular blood flow measurement. // Br. J. Ophthalmol. – 1994. – Vol.78. – P. 939-945.

    161. Yang L., Jonas J.B., Wei W. Optical Coherence Tomography–Assisted Enhanced Depth Imaging of Central Serous Chorioretinopathy // Invest. Ophthalmol. Vis. Sci. - 2013. - Vol.54, № 7. – P. 4659-4665.

    162. Yannuzzi L.A. Type-A behaviour and central serous chorioretinopathy // Retina. – 1987. – Vol.7. – P. 111-130.

    163. Yoshioka H. The etiology of central serous chorioretinopathy // Nihon. Ganka. Gakkai. Zasshi. – 1991. – Vol.95. – P. 1181-1195.

    164. Zhang J.J., Sun Y., Hussain A.A., Marshall J. Laser-mediated activation of human retinal pigment epithelial cells and concomitant release of matrix metalloproteinases // Invest. Ophthalmol. Vis. Sci. – 2012. – Vol.53, № 6. – P. 2928-2937.